Azvudine for the Treatment of COVID-19 in Pre-Existing Cardiovascular Diseases: A Single-Center, Real-World Experience

This study indicated that Azvudine therapy is associated with better outcomes in COVID-19 patients with pre-existing cardiovascular diseases.PMID:38544344 | DOI:10.1002/advs.202306050
Source: Adv Data - Category: Epidemiology Authors: Source Type: research